Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma

被引：0
|
作者：
Lu, Xinli [1 ]
Qian, Cheng [2 ]
机构：
[1] Pharmacy Intravenous Admixture Services, The First People's Hospital of Ningyang County, Tai'an, Shandong,271400, China
[2] Department of Thyroid and Breast Surgery, Zhuji People's Hospital of Zhejiang Province, Zhejiang,311800, China
来源：
Computational and Mathematical Methods in Medicine | 2022年 / 2022卷
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patient treatment
引用
收藏
相关论文
共 50 条
  • [1] RETRACTED: Efficacy, Safety, and Prognosis of Sequential Therapy with Tamoxifen and Letrozole versus Letrozole Monotherapy for Breast Carcinoma (Retracted Article)
    Lu, Xinli
    Qian, Cheng
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [2] Superior efficacy of letrozole versus tamoxifen as first-line therapy
    Buzdar, AU
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 876 - 877
  • [3] Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy
    Smith, IE
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 289 - 293
  • [4] Superior efficacy of letrozole versus tamoxifen as first-line therapy - In Reply
    Mouridsen, H
    Chaudri-Ross, HA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 877 - 878
  • [5] Safety of letrozole and tamoxifen monotherapy: updated BIG 1-98
    Colleoni, M.
    Giobbie-Hurder, A.
    Smith, I.
    Mouridsen, H.
    Romieu, G.
    Neven, P.
    Rabaglio, M.
    Price, K. N.
    Regan, M. M.
    Coates, A. S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 160 - 160
  • [6] Letrozole or tamoxifen in early breast cancer
    Erban, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1529 - 1529
  • [7] Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer
    Buzdar, Aman U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2147 - 2148
  • [8] Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
    Mouridsen, Henning
    Giobbie-Hurder, Anita
    Goldhirsch, Aron
    Thuerlimann, Beat
    Paridaens, Robert
    Smith, Ian
    Mauriac, Louis
    Forbes, John F.
    Price, Karen N.
    Regan, Meredith M.
    Gelber, Richard D.
    Coates, Alan S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 766 - 776
  • [9] Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (02) : 111 - 113
  • [10] Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:: Results of a phase III study of the international letrozole breast cancer group
    Mouridsen, H
    Gershanovich, M
    Sun, Y
    Pérez-Carrión, R
    Boni, C
    Monnier, A
    Apffelstaedt, J
    Smith, R
    Sleeboom, HP
    Jänicke, F
    Pluzanska, A
    Dank, M
    Becquart, D
    Bapsy, PP
    Salminen, E
    Snyder, R
    Lassus, M
    Verbeek, JA
    Staffler, B
    Chaudri-Ross, HA
    Dugan, M
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2596 - 2606
12345